Natural Capsules
188.60
+2.41(+1.29%)
Market Cap₹- Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D+1.29%
1M-8.77%
6M-24.80%
1Y-24.42%
5Y-24.42%
View Company Insightsright
More news about Natural Capsules
04Aug 25
Natural Capsules Reports Mixed Q1 Results: Standalone Profit Amid Consolidated Loss
Natural Capsules reported mixed Q1 financial results. Standalone performance showed growth with Rs 44.24 crore revenue and Rs 2.52 crore net profit. Consolidated results reflected challenges, with Rs 45.20 crore revenue but Rs 5.58 crore net loss. The Capsules segment remained profitable, while the new API segment incurred significant losses. The subsidiary, Natural Biogenex Private Limited, started operations recently and is yet to reach full revenue potential.
Natural Capsules
188.60
+2.41
(+1.29%)
1 Year Returns:-24.42%
Industry Peers
Windlas Biotech
790.15
(+0.55%)
Jeena Sikho Lifecare
699.20
(+0.52%)
Blue Jet Healthcare
554.80
(-2.56%)
Abbott
28,850.00
(-0.14%)
Sunrest Lifescience
42.05
(-2.21%)
Zenith Drugs
54.60
(+2.25%)
Pfizer
5,001.00
(+0.57%)
FDC
414.10
(+0.24%)